Search

Bruker Corp

Chiusa

SettoreSettore sanitario

58.77 -2.84

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

56.39

Massimo

68.65

Metriche Chiave

By Trading Economics

Entrata

-67M

-51M

Vendite

15M

839M

EPS

0.49

Rendimento da dividendi

0.35

Margine di Profitto

-6.07

Dipendenti

11,085

EBITDA

-71M

17M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+17.7% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

0.35%

1.96%

Prossima data del Dividendo

1 gen 2027

Prossima data del' Ex Dividendo

7 dic 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.3B

8.5B

Apertura precedente

61.61

Chiusura precedente

58.77

Bruker Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

4 nov 2026, 21:02 UTC

News

Bruker Corporation reported Q3 revenue of $874 million, exceeding estimates, and a non-GAAP EPS of $0.56, above the expected $0.42.

3 nov 2026, 22:51 UTC

Bruker Corporation is declining in after-market trading, reaching its lowest point of the day and remaining below its 20-day moving average.

2 nov 2026, 21:04 UTC

Correlated Moves

Bruker Corporation shares are declining, continuing a downward trend since Friday's close, alongside a drop in Revvity, Inc.

31 ott 2026, 00:01 UTC

Bruker Corporation's shares were roughly flat during after-market hours on Friday, settling near the lower end of their one-month range.

30 ott 2026, 21:31 UTC

Bruker Corporation's shares have traded lower in after-market hours, retreating from an early high and near the low end of its one-month range.

29 ott 2026, 23:31 UTC

Bruker Corporation's shares are declining in after-market hours amid a broader market downturn, despite earlier recovery attempts during the session.

28 ott 2026, 19:56 UTC

Bruker Corporation shares are higher during Wednesday's session, maintaining a solid position above their 20-day moving average despite a slight retracement from an early spike.

27 ott 2026, 19:52 UTC

Bruker Corporation shares are trading higher, maintaining a position above their 20-day moving average, despite a slight pullback earlier in the session.

26 ott 2026, 19:36 UTC

Bruker Corp shares are trading modestly higher, although they remain below their 20-day moving average and near the lower end of their one-month range.

23 ott 2026, 23:06 UTC

Bruker Corp shares are advancing in after-market hours, tracking the broader market's upward movement despite mixed economic signals and rising oil prices.

22 ott 2026, 20:07 UTC

Correlated Moves

Bruker Corp shares are declining amid broader market weakness, reversing earlier gains despite positive price target upgrades from analysts.

21 ott 2026, 20:01 UTC

Bruker Corp shares are sharply higher, continuing a trend of gains since Tuesday's close amid a broader market shift in dynamics.

20 ott 2026, 21:31 UTC

News

Bruker Corp will release its Q3 2026 financial results on November 4, 2026, and hold a conference call at 8:30 a.m. EDT.

16 ott 2026, 20:07 UTC

Bruker Corp shares are declining, facing consistent selling pressure and closing significantly below the 20-day moving average amid a negative cumulative return for the day.

15 ott 2026, 20:02 UTC

Correlated Moves

Bruker Corp shares are advancing, reflecting a broader trend in the life sciences sector, amid gains in Thermo Fisher Scientific following positive analyst ratings.

14 ott 2026, 20:07 UTC

News

JPMorgan downgraded Bruker Corp from Overweight to Neutral, lowering its price target from $60 to $42, citing a reassessment of growth prospects.

13 ott 2026, 20:07 UTC

Bruker Corp shares fell, remaining near the lower end of their one-month range and below the 20-day moving average.

12 ott 2026, 20:01 UTC

Correlated Moves

Bruker Corp shares are declining amid a significant drop in 10X Genomics Inc, which has reversed a trend of higher daily closes.

8 ott 2026, 20:07 UTC

Bruker Corp shares fell sharply, continuing a three-session decline, after hitting a low shortly after the market opened and closing below the 20-day moving average.

7 ott 2026, 20:07 UTC

News
Correlated Moves

Bruker Corp's stock declined after Barclays raised its price target to $70.00, as market participants viewed the upgrade as insufficiently bullish.

6 ott 2026, 20:00 UTC

Correlated Moves

Bruker Corp shares fell sharply as the overall market declined, influenced by the performance of correlated asset 10X Genomics Inc, which is also lower.

2 ott 2026, 20:07 UTC

Bruker Corp is advancing, maintaining a strong position after closing higher since Thursday, despite pulling back slightly earlier in the session.

1 ott 2026, 19:51 UTC

Bruker Corp shares fell sharply, marking a departure from recent higher daily closes amid a broader market shift in momentum.

30 set 2026, 21:01 UTC

Bruker Corp has declined in after-market trading, reversing earlier regular-session gains, though it remains above its 20-day moving average.

29 set 2026, 23:11 UTC

Bruker Corp is showing an upward movement in after-market trading, with notable gains since Tuesday's close and remaining significantly above its 20-day moving average.

28 set 2026, 20:01 UTC

News

Bruker Corporation's stock fell after an earlier gain, despite unveiling new workflows aimed at advancing drug discovery and disease research at a major conference.

25 set 2026, 20:07 UTC

Bruker Corp shares are modestly higher, supported by a broadly advancing market, and are trading near the upper end of their one-month range.

24 set 2026, 23:15 UTC

Bruker Corp shares are trading modestly higher in after-market hours, supported by positive economic data on jobless claims and new home sales.

23 set 2026, 20:07 UTC

Bruker Corp's shares fell sharply after an early high, despite remaining above the 20-day moving average and near the upper end of its one-month range.

22 set 2026, 23:01 UTC

Bruker Corp is advancing in after-market trading, reaching a peak return and remaining well above its 20-day moving average.

Confronto tra pari

Modifica del prezzo

Bruker Corp Previsione

Obiettivo di Prezzo

By TipRanks

17.7% in crescita

Previsioni per 12 mesi

Media 66.5 USD  17.7%

Alto 80 USD

Basso 55 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Bruker Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

6 ratings

3

Acquista

2

Mantieni

1

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
help-icon Live chat